Aurum Consulting Group is a premier strategic delivery partner to the world’s leading management consulting and investment banking firms, specialising in biotechnology, healthcare, and life sciences.
Founded by former MBB consultants and top-tier investment banking professionals, Aurum exists to bridge the gap between scientific innovation and commercial reality — delivering unparalleled strategic execution from lab bench to market leadership.
We operate at the intersection of science, strategy, and capital, supporting high-stakes projects where technical precision, regulatory mastery, and commercial viability are critical to success.
Our team brings a rare combination of scientific depth, strategic rigor, transaction fluency, and operational excellence — empowering consulting teams and investors to accelerate innovation, capture value, and drive transformational outcomes across diagnostics, therapeutics, and healthcare ventures.
At Aurum, we do not merely advise. We build, execute, and deliver — with the discipline of consultants, the judgment of bankers, and the insight of scientists.
Company Details
- Founded
- -
- Address
- Melbourne , Victoria, Au
- Industry
- Business Consulting And Services
- NAICS
-
Management, Scientific, and Technical Consulting ServicesManagement Consulting ServicesOther Scientific and Technical Consulting ServicesOther Management Consulting Services
- Keywords
- Melbourne.
- HQ
- Melbourne , Victoria
Aurum Consulting Group Questions
Aurum Consulting Group's LinkedIn profile is https://au.linkedin.com/company/aurum-consulting-group
Aurum Consulting Group's industry is
Business Consulting and Services
Aurum Consulting Group's top competitors are
Palindrome Biotech Consulting Pty Ltd,
Biogenys,
Aurum Cg,
Mygene Pty Ltd,
Andes Biotech Life Science Consulting,
Evolution Capital Pty Ltd,
Lodge Partners,
Nuvera Life Science Consulting,
Rms Biotech Consulting,
Ownership Matters.
Aurum Consulting Group's categories are Business Consulting and Services
Aurum Consulting Group's founding year is 2025
